Fluoroquinolone Resistance inSalmonella entericaSerotype Choleraesuis, Taiwan, 2000–2003
Open Access
- 1 September 2004
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 10 (9) , 1674-1676
- https://doi.org/10.3201/eid1009.030596
Abstract
Salmonella enterica serotype Choleraesuis is a highly invasive pathogen that infects humans and causes systemic infections that require antimicrobial therapy. Surveillance in Taiwan showed that fluoroquinolone resistance in S. Choleraesuis markedly increased from 2000 to 2003, reaching approximately 70% in 2003.Keywords
This publication has 7 references indexed in Scilit:
- Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacinThe Lancet, 2004
- Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, TaiwanEmerging Infectious Diseases, 2004
- The Emergence in Taiwan of Fluoroquinolone Resistance inSalmonella entericaSerotype CholeraesuisNew England Journal of Medicine, 2002
- Secular trends in incidence and antimicrobial resistance among clinical isolates of salmonella at a university hospital in Taiwan, 1983–1999Epidemiology and Infection, 2001
- Large Drug Resistance Virulence Plasmids of Clinical Isolates ofSalmonella entericaSerovar CholeraesuisAntimicrobial Agents and Chemotherapy, 2001
- PREDICTORS FOR EXTRAINTESTINAL INFECTION OF NON‐TYPHOIDAL SALMONELLA IN PATIENTS WITHOUT AIDSInternational Journal Of Clinical Practice, 1999
- Epidemiological study of human salmonellosis during 1991-1996 in southern Taiwan.1999